Sign inJoin waitlistJoin the waitlist

Rahul Aggarwal

Professor in Residence · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
Present

Hematology and Medical Oncology
University of California-San Francisco
2010–2013
Internal Medicine
School of Medicine
2006–2009
Feinberg School of Medicine
2002–2006

Research

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Journal of Clinical Oncology · 2018 · First of 31 authors · 673 citations
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Cell · 2018 · 551 citations
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Journal of the National Cancer Institute · 2017 · 336 citations

Eric Small
80 papers
Felix Feng
43 papers
Joshi Alumkal
34 papers
CR
Charles Ryan
30 papers
Jiaoti Huang
22 papers · 4 as a resident
TB
Tomasz Beer
22 papers
Terence Friedlander
21 papers
Jonathan Chou
20 papers · 5 as a fellow
Matthew Rettig
20 papers
Lawrence Fong
18 papers
Christopher Evans
17 papers
Daniel Kwon
17 papers · 7 as a fellow

Grants

A Novel Chemical Strategy to Harness the Tumor Specific Biochemistry of Human Kallikrein 2 for Prostate Cancer Theranostics
National Cancer Institute · R01
PI · $575.2K · University of California, San Francisco
2026–2031
Maximizing Tumor Responses to Targeted Radiotherapy with a Conditionally Activated Membrane Binding Probe
National Cancer Institute · R01
PI · $1.9M · University of California, San Francisco
2023–2028
Molecular Imaging of Novel PARP Inhibitor Nanomedicine Delivery
National Cancer Institute · R01
PI · $2.4M · University of California, San Francisco
2022–2027
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring
National Cancer Institute · R01
PI · $3.3M · University of California, San Francisco
2020–2026

Clinical trials

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Principal investigator · Recruiting · Phase 1
University of California, San Francisco
2026–2030
Imaging of Solid Tumors Using 18F-TRX
Principal investigator · Recruiting · Phase 1
Rahul Aggarwal
2025–2027
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
2023–2031
64Cu-GRIP B in Patients With Advanced Malignancies
Principal investigator · Recruiting · Phase 1, Phase 2
Rahul Aggarwal
2023–2027